189 related articles for article (PubMed ID: 10416040)
21. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
BMC Neurosci; 2014 Jan; 15():21. PubMed ID: 24483602
[TBL] [Abstract][Full Text] [Related]
22. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
Sharma SK; El Refaey H; Ebadi M
Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
[TBL] [Abstract][Full Text] [Related]
23. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice.
Sohal RS; Kamzalov S; Sumien N; Ferguson M; Rebrin I; Heinrich KR; Forster MJ
Free Radic Biol Med; 2006 Feb; 40(3):480-7. PubMed ID: 16443163
[TBL] [Abstract][Full Text] [Related]
24. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
27. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension.
Tran MT; Mitchell TM; Kennedy DT; Giles JT
Pharmacotherapy; 2001 Jul; 21(7):797-806. PubMed ID: 11444576
[TBL] [Abstract][Full Text] [Related]
28. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J; Kompoliti K; Perlmutter JS; Reich S; Stern M; Watts RL; Kurlan R; Molho E; Harrison M; Lew M;
Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491
[TBL] [Abstract][Full Text] [Related]
29. The effect of coenzyme Q10 on sperm motility and function.
Lewin A; Lavon H
Mol Aspects Med; 1997; 18 Suppl():S213-9. PubMed ID: 9266524
[TBL] [Abstract][Full Text] [Related]
30. Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
Beal MF; Shults CW
Biofactors; 2003; 18(1-4):153-61. PubMed ID: 14695931
[No Abstract] [Full Text] [Related]
31. Antioxidants, supplements, and Parkinson's disease.
Weber CA; Ernst ME
Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
Attia HN; Maklad YA
Behav Pharmacol; 2018 Feb; 29(1):79-86. PubMed ID: 28902670
[TBL] [Abstract][Full Text] [Related]
33. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
35. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B
Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
Müller T; Büttner T; Gholipour AF; Kuhn W
Neurosci Lett; 2003 May; 341(3):201-4. PubMed ID: 12697283
[TBL] [Abstract][Full Text] [Related]
37. Coenzyme Q10 for Parkinson's disease.
Liu J; Wang L; Zhan SY; Xia Y
Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
[TBL] [Abstract][Full Text] [Related]
38. [Coenzyme Q10: biochemistry, pathophysiology of its deficiency and potential benefit of an increased intake].
Malchair P; Van Overmeire L; Boland A; Salmon E; Pierard L; Seutin V
Rev Med Liege; 2005 Jan; 60(1):45-51. PubMed ID: 15771317
[TBL] [Abstract][Full Text] [Related]
39. Coenzyme Q10 in neurodegenerative diseases.
Shults CW
Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease.
Ogawa O; Zhu X; Perry G; Smith MA
Sci Aging Knowledge Environ; 2002 Oct; 2002(41):pe16. PubMed ID: 14603007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
